Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthcare Services (HCSG) Shares Outstanding (Diluted Average) (2016 - 2026)

Healthcare Services has reported Shares Outstanding (Diluted Average) over the past 18 years, most recently at $71.0 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 3.94% to $71.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $71.0 million through Mar 2026, down 3.94% year-over-year, with the annual reading at $73.0 million for FY2025, 1.29% down from the prior year.
  • Shares Outstanding (Diluted Average) was $71.0 million for Q1 2026 at Healthcare Services, down from $73.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $74.5 million in Q2 2023 and troughed at $71.0 million in Q1 2026.
  • The 5-year median for Shares Outstanding (Diluted Average) is $74.1 million (2024), against an average of $73.9 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 0.25% in 2023 and later fell 3.94% in 2026.
  • Tracing HCSG's Shares Outstanding (Diluted Average) over 5 years: stood at $74.4 million in 2022, then fell by 0.01% to $74.3 million in 2023, then decreased by 0.47% to $74.0 million in 2024, then fell by 1.29% to $73.0 million in 2025, then dropped by 2.72% to $71.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $71.0 million, $73.0 million, and $73.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.